Stephen L. Eck
Chief Medical Officer at Macrogenics Inc (MGNX)
Stephen L. Eck has filed 8 insider reports with the SEC since February 2021, as chief Medical Officer at Macrogenics Inc (MGNX) and director at Luminex Corp (LMNX). The latest filing, on February 19, 2025, reports shares withheld for taxes or exercise price and exercise or conversion of a derivative at Macrogenics Inc (MGNX).
- Filings
- 8
- Companies
- 2
- Bought on market
- None
- Sold on market
- None
Companies where Stephen L. Eck is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Medical Officer | 29,377 | $1.96 | Feb 19, 2025 | ||||
| Director | 0 | Jul 15, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Feb 15, 2025MGNXChief Medical Officer Eck Stephen L. converted options into 16,665 shares and covered exercise/tax liability with 4,942 shares, increasing direct ownership by 66% to 29,377 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Feb 8, 2025MGNXChief Medical Officer Eck Stephen L. converted options into 11,168 shares and covered exercise/tax liability with 3,312 shares, increasing direct ownership by 80% to 17,654 unitsForm 4Grant or awardShares withheld for taxes or exercise priceExercise or conversion of a derivative
- Feb 15, 2024MGNXEck Stephen L. converted options into 16,670 shares and covered exercise/tax liability with 6,872 sharesForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Feb 8, 2024MGNXSEC Form 4 filed by Eck Stephen L.Form 4Grant or award
- Feb 15, 2023MGNXSEC Form 4 filed by Eck Stephen L.Form 4Grant or award
- Feb 22, 2022MGNXSEC Form 4 filed by Eck Stephen L.Form 4Grant or award
- Jul 14, 2021LMNXSEC Form 4: Eck Stephen L. returned $1,408,701 worth of Common Stock to the company (38,073 units at $37.00) , closing all direct ownership in the company (for withholding tax)Form 4Sale back to the company
- Feb 22, 2021MGNXSEC Form 4 filed by L. Stephen EckForm 4Grant or award
Compare Stephen L. Eck with
- Stephen L. Eck vs Michael Vasconcelles1 shared
- Stephen L. Eck vs Emil Kuriakose1 shared
- Stephen L. Eck vs Jeffrey Stuart Peters1 shared
- Stephen L. Eck vs Ezio Bonvini1 shared
- Stephen L. Eck vs Scott Thomas Jackson1 shared
- Stephen L. Eck vs Federica F. O'Brien1 shared
Other insiders at the same companies
- Michael VasconcellesMGNX
- Emil KuriakoseMGNX
- Jeffrey Stuart PetersMGNX
- Ezio BonviniMGNX
- Scott Thomas JacksonMGNX
- Federica F. O'BrienMGNX
- William K HeidenMGNX
- Jay Philip SiegelMGNX
- Margaret LiuMGNX
- Meenu ChhabraMGNX
- Edward HurwitzMGNX
- David C StumpMGNX
- Scott KoenigMGNX
- Karen Jean FerranteMGNX
- Beth Ann SmithMGNX
- James KarrelsMGNX
Questions about Stephen L. Eck
- What is Stephen L. Eck's role at Macrogenics Inc?
- Stephen L. Eck reports to the SEC as chief Medical Officer at Macrogenics Inc (MGNX), according to the latest filing on February 19, 2025. Stephen L. Eck has also filed as director at Luminex Corp (LMNX).
- How many shares does Stephen L. Eck own?
- After the latest filing that states it, Stephen L. Eck directly owned 29,377 shares of Macrogenics Inc (MGNX). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Stephen L. Eck bought or sold stock recently?
- No open-market purchases or sales by Stephen L. Eck are on file. The filings report shares withheld for taxes or exercise price, exercise or conversion of a derivative, grant or award and sale back to the company.
- How do I get alerts when Stephen L. Eck files?
- Follow Stephen L. Eck on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Stephen L. Eck (SEC CIK 0001669041). Totals count each trade once, skipping amendments whose original is on file, from Feb 24, 2021 on. View on SEC EDGAR · Get this as JSON